Company Filing History:
Years Active: 2024
Title: Baomei Wang: Innovator in Chimeric Autoantibody Receptor T Cells
Introduction
Baomei Wang is a prominent inventor based in Philadelphia, PA. He has made significant contributions to the field of immunology through his innovative research and inventions. His work focuses on developing advanced therapeutic methods for autoimmune diseases.
Latest Patents
Baomei Wang holds a patent for "Compositions and methods of phospholipase A2 receptor chimeric autoantibody receptor T cells." This invention includes compositions comprising at least one chimeric autoantibody receptor (CAAR) specific for an anti-phospholipase A2 receptor (PLA2R) autoantibody-based B cell receptor. The patent also covers polynucleotides encoding the CAAR, vectors comprising a polynucleotide encoding the CAAR, and recombinant T cells that express the CAAR. Additionally, the invention outlines methods for creating genetically modified cells, such as T cells, that express a PLA2R-CAAR, which includes a PLA2R extracellular domain.
Career Highlights
Baomei Wang is affiliated with the University of Pennsylvania, where he conducts his research and development work. His innovative approach to immunotherapy has garnered attention in the scientific community, contributing to advancements in treating autoimmune conditions.
Collaborations
Baomei Wang collaborates with notable colleagues, including Saar Gill and Jonathan Hogan. Their combined expertise enhances the research efforts and drives innovation in their field.
Conclusion
Baomei Wang's contributions to the development of chimeric autoantibody receptor T cells represent a significant advancement in immunotherapy. His work continues to pave the way for new treatment options for patients with autoimmune diseases.